Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1958 Feb;33(167):31–45. doi: 10.1136/adc.33.167.31

The Dietary Treatment of Phenylketonuria

L I Woolf, Ruth Griffiths, Alan Moncrieff, Stephen Coates, F Dillistone
PMCID: PMC2012184  PMID: 13509741

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG M. D., ROBINSON K. S. On the excretion of indole derivatives in phenylketonuria. Arch Biochem Biophys. 1954 Sep;52(1):287–288. doi: 10.1016/0003-9861(54)90115-0. [DOI] [PubMed] [Google Scholar]
  2. ARMSTRONG M. D., TYLER F. H. Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria. J Clin Invest. 1955 Apr;34(4):565–580. doi: 10.1172/JCI103105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BERRY J. P., WOOLF L. I. Estimation of phenylpyruvic acid. Nature. 1952 Feb 2;169(4292):202–203. doi: 10.1038/169202a0. [DOI] [PubMed] [Google Scholar]
  4. BICKEL H., GERRARD J., HICKMANS E. M. Influence of phenylalanine intake on phenylketonuria. Lancet. 1953 Oct 17;265(6790):812–813. doi: 10.1016/s0140-6736(53)90473-5. [DOI] [PubMed] [Google Scholar]
  5. BLAINEY J. D., GULLIFORD R. Phenylalanine-restricted diets in the treatment of phenylketonuria. Arch Dis Child. 1956 Dec;31(160):452–466. doi: 10.1136/adc.31.160.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BLASCHKO H., DATTA S. P., HARRIS H. Pyridoxin deficiency in the rat; liver L-cysteic acid decarboxylase activity and urinary amino-acids. Br J Nutr. 1953;7(4):364–371. doi: 10.1079/bjn19530046. [DOI] [PubMed] [Google Scholar]
  7. BRAUDE H. Phenylketonuria; a case report in a European child treated with a diet low in phenylalanine. S Afr Med J. 1956 Jan 28;30(4):83–85. [PubMed] [Google Scholar]
  8. COATES S., NORMAN A. P., WOOLF L. I. Phenylketonuria with normal intelligence and Gowers' muscular dystrophy. Arch Dis Child. 1957 Aug;32(164):313–317. doi: 10.1136/adc.32.164.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. COLLINS R. A., HARPER A. E., SCHREIBER M., ELVEHJEM C. A. The folic acid and vitamin B12 content of the milk of various species. J Nutr. 1951 Feb;43(2):313–321. doi: 10.1093/jn/43.2.313. [DOI] [PubMed] [Google Scholar]
  10. COWIE V. Phenylpyruvic oligophrenia. J Ment Sci. 1951 Jul;97(408):505–531. doi: 10.1192/bjp.97.408.505. [DOI] [PubMed] [Google Scholar]
  11. DANCIS J., BALIS M. E. A possible mechanism for disturbance in tyrosine metabolism in phenylpyruvic oligophrenia. Pediatrics. 1955 Jan;15(1):63–66. [PubMed] [Google Scholar]
  12. HORNER F. A., STREAMER C. W. Effect of a phenylalanine-restricted diet on patients with phenylketonuria; clinical observations in three cases. J Am Med Assoc. 1956 Aug 25;161(17):1628–1630. doi: 10.1001/jama.1956.62970170004005b. [DOI] [PubMed] [Google Scholar]
  13. MUNRO H. N., THOMSON W. S. Influence of glucose on amino acid metabolism. Metabolism. 1953 Jul;2(4):354–361. [PubMed] [Google Scholar]
  14. PARE C. M., SANDLER M., STACEY R. S. 5-Hydroxytryptamine deficiency in phenylketonuria. Lancet. 1957 Mar 16;272(6968):551–553. doi: 10.1016/s0140-6736(57)90920-0. [DOI] [PubMed] [Google Scholar]
  15. PENROSE L. S. Measurement of pleiotropic effects in phenylketonuria. Ann Eugen. 1951 Sep;16(2):134–141. doi: 10.1111/j.1469-1809.1951.tb02467.x. [DOI] [PubMed] [Google Scholar]
  16. WOLF H. Zur Behandlung des sogenannten Phenylbrenztraubensäure-Schwachsinns (Oligophrenia phenylpyruvica). Medizinische. 1956 Jun 16;(24):883–886. [PubMed] [Google Scholar]
  17. WOOLF L. I., VULLIAMY D. G. Phenylketonuria with a study of the effect upon it of glutamic acid. Arch Dis Child. 1951 Dec;26(130):487–494. doi: 10.1136/adc.26.130.487. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES